Effectiveness of Nicotine Replacement Therapy (NRT) and Bupropion for Smoking Cessation amongst opioid dependent subjects on agonist maintenance treatment: A Randomized Open-Label, Parallel-Group Trial - NI

ational Drug Dependent Treatment Centre0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年5月27日

研究概览

暂无简介。

•Age 18 to 60 years
•Current (last 1 month) user of tobacco by smoking route
•Diagnosed with nicotine dependence, current use as per ICD-11 criteria
•Currently following up in NDDTC OPD for Opioid agonist maintenance treatment (Buprenorphine-Naloxone) with 80% medication dispensing
•Willing to participate in follow up at 4-6 weeks and 12-14 weeks

•History of co-morbid psychiatric illnesses (as per clinical interview)
•Current (last 1 month)Dependence on drugs other than opioid and nicotine
•Current users of smokeless tobacco
•Has ever received tobacco cessation intervention (except simple advice from a health care professional) in the past 3 months
•Unwilling to give informed consent
•Contraindication for Nicotine replacement therapy (accelerated hypertension, post-myocardial infarction period (2 weeks), hypersensitivity to NRT) or Bupropion (Seizure episode, eating disorder)

发起方

ational Drug Dependent Treatment Centre